Decoy Therapeutics Inc.
DCOY· Nasdaq
DCOYDecoy Therapeutics Inc.
Filed Mar 8, 2017 · 10-K · 67 days after period end · 0001615219-17-000021
| Metric | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|
| Revenue | $298.90K | — | — |
| Net Income | -$7.90M | -$7.89M | -$3.74M |
| EPS Diluted | -$0.48 | -$0.51 | -$1.82 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Decoy Therapeutics Inc. · CIK 1615219 · Engraved from SEC EDGAR
ended Dec 31, 2016 · filed Mar 8, 2017 · 67 d after period end
